We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




DeepMind Masters Retinal Disease Detection

By HospiMedica International staff writers
Posted on 27 Aug 2018
Artificial intelligence (AI) can accurately detect 53 kinds of sight-threatening retinopathy at least as effectively as experts, claims a new study.

Researchers at Google DeepMind (London, United Kingdom), Moorfields Eye Hospital (London, United Kingdom), and University College London (UCL, United Kingdom), first trained a deep learning AI algorithm to spot ten different features of eye disease, based on 14,884 three-dimensional (3D), high-definition optical coherence tomography (OCT) retinal scans. More...
The researchers then gathered another 997 scans and asked DeepMind and eight consultant ophthalmologists and specialist optometrists to recommend urgent referral, semi-urgent referral, routine referral, or observation for each scan.

In the most crucial category, urgent referral, DeepMind matched the two top retina specialists and had a significantly higher performance rate than the other two specialists and all four optometrists. No cases of urgent referral were missed by the system. When all referral types were taken into consideration, computer error rate was 5.5%, comparable to the error rate for the two best retina specialists (6.7% and 6.8%) and significantly better than the other six experts. When the clinicians had access to the OCT scans, fundus images, and patient summary notes, five had similar accuracy to the AI system, whereas the system still outperformed the other three. The study was published on August 13, 2018, in Nature Medicine.

“We set up DeepMind because we wanted to use AI to help solve some of society's biggest challenges, and diabetic retinopathy is the fastest growing cause of blindness worldwide. There are more than 350 million sufferers across the planet,” said co-senior study author Mustafa Suleyman, co-founder of DeepMind. “Detecting eye diseases as early as possible gives patients the best possible chance of getting the right treatments. I really believe that one day this work will be a great benefit to patients across the NHS.”

“Our research with DeepMind has the potential to revolutionize the way professionals carry out eye tests, and could lead to earlier detection and treatment of common eye diseases such as age-related macular degeneration,” said Professor Sir Peng Tee Khaw, MD, director of the Biomedical Research Centre in Ophthalmology at Moorfields Eye Hospital. “With sight loss predicted to double by the year 2050, it is vital we explore the use of cutting-edge technology to prevent eye disease.”

DeepMind is a British artificial intelligence company founded in September 2010 which created a neural network that learns how to play video games in a fashion similar to that of humans, as well as a neural network that may be able to access an external memory like a conventional Turing machine, resulting in a computer that mimics the short-term memory of the human brain; it was acquired by Google in 2014.

Related Links:
Google DeepMind
Moorfields Eye Hospital
University College London

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
X-Ray Meter
Cobia SENSE
Silver Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Miniaturized electric generators based on hydrogels for use in biomedical devices (Photo courtesy of HKU)

Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices

The development of engineered devices that can harvest and convert the mechanical motion of the human body into electricity is essential for powering bioelectronic devices. This mechanoelectrical energy... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.